Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Sionna Therapeutics, Inc. (SION) had Weighted-Average Shares Outstanding (Diluted) of 26.60M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-16.48M |
|
-- |
|
-- |
|
$19.66M |
|
$-19.66M |
|
$3.18M |
|
$-16.48M |
|
$-16.48M |
|
$-16.48M |
|
$-16.48M |
|
$-16.48M |
|
$-16.48M |
|
$-19.66M |
|
$-20.20M |
|
26.60M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
26.60M |
$-0.62 |
|
$-0.62 |
|
| Balance Sheet Financials | |
$273.68M |
|
$2.39M |
|
$95.99M |
|
$369.67M |
|
$9.53M |
|
-- |
|
$8.38M |
|
$17.91M |
|
$351.77M |
|
$351.77M |
|
$351.77M |
|
44.09M |
|
| Cash Flow Statement Financials | |
$-16.29M |
|
$-141.19M |
|
$202.39M |
|
$38.75M |
|
$83.66M |
|
$44.91M |
|
$2.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.69% |
|
-4.69% |
|
-4.46% |
|
-4.69% |
|
$7.98 |
|
$-0.62 |
|
$-0.61 |
|